Sotera Health (SHC) Cash from Investing Activities (2020 - 2026)
Sotera Health (SHC) recorded quarterly Cash from Investing Activities of -$45.1 million in Q1 2026, up 10.99% quarter-over-quarter from -$50.7 million in Q4 2025, and down 126.99% on a YoY basis from $167.2 million in Q1 2025.
Sotera Health (SHC) Cash from Investing Activities (2020 - 2026) Analysis & Trends
Sotera Health's Cash from Investing Activities history runs 7 years deep, the most recent figure standing at -$45.1 million for Q1 2026.
- In Q1 2026, Cash from Investing Activities fell 126.99% year-over-year to -$45.1 million; the TTM figure through Mar 2026 stood at -$160.4 million (up 2.21% YoY), while the FY2025 annual figure was -$135.1 million, up 24.5% from the prior year.
- Cash from Investing Activities was -$45.1 million for Q1 2026 at Sotera Health, up from -$50.7 million in the prior quarter.
- In the past five years, Cash from Investing Activities ranged from a high of -$19.9 million in Q1 2025 to a low of -$71.7 million in Q4 2022.
- Historically, Cash from Investing Activities has averaged -$44.5 million across 5 years, with a median of -$41.9 million in 2024.
- The sharpest annual moves came in 2022 and 2025: Cash from Investing Activities slumped 134.79% in 2022, then soared 42.96% in 2025.
- A 5-year view of Cash from Investing Activities shows it stood at -$71.7 million in 2022, then advanced by 9.64% to -$64.8 million in 2023, then dropped by 1.61% to -$65.9 million in 2024, then rose by 23.03% to -$50.7 million in 2025, then rose by 10.99% to -$45.1 million in 2026.
- The last three Cash from Investing Activities figures came in at -$45.1 million (Q1 2026), -$50.7 million (Q4 2025), and -$33.3 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Waters | 30,529.42 Bn | 30,528.96 Bn | 1.11 Bn | 95.00 Mn |
| 2 | Thermo Fisher Scientific | 183.75 Bn | 180.50 Bn | 7.74 Bn | -8.96 Bn |
| 3 | Danaher | 133.13 Bn | 127.43 Bn | 3.59 Bn | -249.00 Mn |
| 4 | Idexx Laboratories | 46.14 Bn | 45.94 Bn | 722.74 Mn | -33.54 Mn |
| 5 | Agilent Technologies | 38.20 Bn | 36.39 Bn | 990.00 Mn | -77.00 Mn |
| 6 | Natera | 31.50 Bn | 30.40 Bn | 696.04 Mn | -32.14 Mn |
| 7 | Iqvia Holdings | 31.34 Bn | 29.36 Bn | 1.36 Bn | -196.00 Mn |
| 8 | Illumina | 24.51 Bn | 23.36 Bn | 721.00 Mn | -366.00 Mn |
| 9 | Mettler Toledo International | 23.53 Bn | 23.47 Bn | 555.82 Mn | -31.35 Mn |
| 10 | Sotera Health | 4.72 Bn | 4.40 Bn | 147.07 Mn | -45.13 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -45.13 Mn |
| Mar 31, 2026 | -45.13 Mn |
| Dec 31, 2025 | -50.70 Mn |
| Dec 31, 2025 | -50.70 Mn |
| Sep 30, 2025 | -33.34 Mn |
| Sep 30, 2025 | -33.34 Mn |
| Jun 30, 2025 | -31.23 Mn |
| Jun 30, 2025 | -31.23 Mn |
| Mar 31, 2025 | -19.88 Mn |
| Mar 31, 2025 | -19.88 Mn |
| Dec 31, 2024 | -65.87 Mn |
| Dec 31, 2024 | -65.87 Mn |
| Sep 30, 2024 | -36.35 Mn |
| Sep 30, 2024 | -36.35 Mn |
| Jun 30, 2024 | -41.92 Mn |
| Jun 30, 2024 | -41.92 Mn |
| Mar 31, 2024 | -34.85 Mn |
| Mar 31, 2024 | -34.85 Mn |
| Dec 31, 2023 | -64.83 Mn |
| Dec 31, 2023 | -64.83 Mn |